These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 725864)
1. [Platelet inhibitory agents in the prevention of infarct]. Stormorken H Tidsskr Nor Laegeforen; 1978 Oct; 98(30):1523-4. PubMed ID: 725864 [No Abstract] [Full Text] [Related]
2. Antiplatelet agents in prevention of myocardial infarction. Kshirsagar NA Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947 [No Abstract] [Full Text] [Related]
3. [Blood platelets and myocardial infarction]. MusiaĆ J; Dworski R; Szczeklik A Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594 [No Abstract] [Full Text] [Related]
5. [Prevention of myocardial infarction by chemotherapy]. Toshima H; Adachi K Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172 [No Abstract] [Full Text] [Related]
6. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review]. Verdecchia P G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978 [No Abstract] [Full Text] [Related]
8. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position. McNicol GP Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840 [No Abstract] [Full Text] [Related]
9. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients. Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008 [No Abstract] [Full Text] [Related]
10. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]
13. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
14. Secondary prevention of myocardial infarction--the present state of the ART. Mitchell JR Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236 [No Abstract] [Full Text] [Related]
15. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]
16. [Prevention of recurrent myocardial infarct]. Kallio V Duodecim; 1981; 97(5):227-30. PubMed ID: 6113128 [No Abstract] [Full Text] [Related]
18. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cairns JA Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983 [No Abstract] [Full Text] [Related]
19. Secondary prevention of myocardial infarction. Davies JA Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H; Avenarius HJ Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]